Company / Operating Income per Share
Edgewise Therapeutics, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.86
FY2025
5-year range
-$1.86 / -$1.15
FY2021-FY2025
Trend
-8.2%
vs FY2024
Sector context
#114 of 201
Health Care
What the data says
At $-1.86, Edgewise Therapeutics, Inc.'s operating income per share ranks #114 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 6 years, ranging from $-23.26 in FY2020 to $-1.15 in FY2021.
Based on SEC 10-K filings.
-1.86 in FY2025.
Declined from $-1.79 to $-1.86 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 201 in Health CareTop 57% of 201This company -$1.86 Sector average -$3.23
▼
+42.5% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 8.2% year-over-year.
- Ranks #114 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.86 | -8.2% |
| FY2024 | -$1.72 | +4.2% |
| FY2023 | -$1.79 | -34.2% |
| FY2022 | -$1.34 | -16.1% |
| FY2021 | -$1.15 | +95.0% |
| FY2020 | -$23.26 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026